Detalhe da pesquisa
1.
Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.
CA Cancer J Clin
; 69(5): 402-429, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31283845
2.
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet
; 402(10405): 871-881, 2023 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478883
3.
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Future Oncol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357801
4.
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.
Lancet Oncol
; 23(10): 1321-1331, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087590
5.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485464
6.
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.
Future Oncol
; 18(7): 781-791, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918546
7.
Outcomes of Critically Ill Lung Cancer Patients Initiating Targeted Therapy or Immunotherapy in the Intensive Care Unit: A Single-Center Report.
J Intensive Care Med
; 37(8): 1055-1059, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34787022
8.
A Mindfulness-Based Intervention as a Supportive Care Strategy for Patients with Metastatic Non-Small Cell Lung Cancer and Their Spouses: Results of a Three-Arm Pilot Randomized Controlled Trial.
Oncologist
; 25(11): e1794-e1802, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32621630
9.
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Oncologist
; 25(10): e1457-e1463, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608142
10.
Use of Immune Checkpoint Inhibitors in Mesothelioma.
Curr Treat Options Oncol
; 20(2): 18, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30762130
11.
Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas.
Oncologist
; 23(5): 526-e49, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371473
12.
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
Lancet Oncol
; 18(9): 1261-1273, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729154
13.
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
Lancet Oncol
; 17(12): 1672-1682, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789196
14.
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Lancet Oncol
; 16(4): 447-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800891
15.
Local and systemic therapies for malignant pleural mesothelioma.
Curr Treat Options Oncol
; 15(4): 683-99, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25266654
16.
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.
Ann Diagn Pathol
; 18(3): 140-5, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24747001
17.
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC.
J Thorac Oncol
; 19(3): 500-506, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012986
18.
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
JAMA Oncol
; 10(4): 475-483, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358753
19.
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets.
JTO Clin Res Rep
; 5(2): 100623, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357092
20.
Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival.
J Thorac Cardiovasc Surg
; 166(2): 362-371.e9, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737380